Tag: Cassava Sciences controversy
The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage
The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...